REFERENCES
- Berry , D. ( 1987 ). Logarithmic transformations in ANOVA . Biometrics 43 : 439 – 456 . [PUBMED] [INFOTRIEVE] [CSA]
- Brittain , E. , Lin , D. ( 2003 ). Non-Inferiority Trials of Antibiotic Therapy . FDA-Industry Workshop .
- Campbell , G. , Yue , L. ( 2003 ). Active Control Non-Inferiority Studies in Medical Devices . FDA-Industry Workshop .
- Chi , G. Y. H. , Chen , G. , Rothmann , M. , Li , N. ( 2003 ). Active control trials . Encylopedia of Biopharmaceutical Statistics 9 – 15 . [CSA]
- Chen , G. , Wang , Y. C. , Chi , G. Y. H. ( 2004 ). Hypotheses and type I error in active control non-inferiority trials . Journal of Biopharmaceutical Statistics 14 ( 2 ): 301 – 303 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Ellenberg , S. S. , Temple , R. ( 2000 ). Placebo-controlled trials and active-control trials in the evaluation of new treatments—Part 2: Practical issues and specific cases . Annals of Internal Medicine 133 : 464 – 470 . [PUBMED] [INFOTRIEVE] [CSA]
- FDA . ( 2001 ). Medical-Statistical Review for Xeloda (NDA 20-896) . FDA Division of Freedom of Information, Rockville, MD, dated 23 April, 2001 .
- Fisher , L. D. , Gent , M. , Buller , H. R. ( 2001 ). How would a new agent compare with placebo? a method illustrated with clopidogrel, aspirin, and placebo . American Heart Journal 141 : 26 – 32 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Fleming , T. R. , Harrington , D. ( 1991 ). Counting Processes and Survival Analysis . New York : Wiley .
- Hasselblad , V. , Kong , D. F. ( 2001 ). Statistical methods for comparison to placebo in active-control trials . Drug Information Journal 35 : 435 – 449 . [CSA]
- Hauck , W. , Anderson , S. ( 1999 ). Some issues in the design and analysis of equivalence trials . Drug Information Journal 33 : 109 – 118 . [CSA]
- Hauschke , D. , Kieser , M. , Diletti , E. , Burke , M. ( 1999 ). Sample size determination for proving equivalence based on the ratio of two means for normally distribution data . Statistics in Medicine 18 : 93 – 105 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Holmgren , E. B. ( 1999 ). Establishing equivalence by showing that a prespecified percentage of the effect of the active control over placebo is maintained . Journal of Biopharmaceutical Statistics 9 ( 4 ): 651 – 659 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Hung , H. M. J. , Wang , S. J. , Tsong , Y. , Lawrence , J. , O'Neill , R. T. (2003). Some fundamental issues for non-inferiority testing in active controlled trials. Stat. Medicine 22:213–225. [CSA]
- Koch , G. G. , Tangen , C. M. ( 1999 ). Nonparametric analysis of covariance and its role in non-inferiority clinical trials . Drug Information Journal 33 : 1145 – 1159 . [CSA]
- Ng , T. H. ( 1993 ). A specification of treatment difference in the design of clinical trials with active controls . Drug Information Journal 27 : 705 – 719 . [CSA]
- Pigeot , I. , Schafer , J. , Rvhmel , J. , Hauschke , D. ( 2001 ). Assessing the therapeutic equivalence of two treatments in comparison with a placebo group . Statistics in Medicine 22 : 883 – 899 . [CSA] [CROSSREF]
- Rothmann , M. , Li , N. , Chen , G. , Chi , G. Y. H. , Temple , R. , Tsou , H. H. ( 2003 ). Design and analysis of non-inferiority mortality trials in oncology . Statistics in Medicine 22 : 239 – 264 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Temple , R. ( 1996 ). Problem in interpreting active control equivalence trials . Accountability in Research 4 : 267 – 275 . [PUBMED] [INFOTRIEVE] [CSA]
- Temple , R. , Ellenberg , S. S. ( 2000 ). Placebo-controlled trials and active-control trials in the evaluation of new treatments—Part 1: Ethical and scientific issues . Annals of Internal Medicine 133 : 455 – 463 . [PUBMED] [INFOTRIEVE] [CSA]
- Wang , S. J. , Hung , H. M. ( 2003 ). TACT method for non-inferiority testing in active controlled trials . Statistics in Medicine 22 : 227 – 238 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- Walton , M. , Gupta , S. ( 2003 ). Non-Inferiority Margin Setting: Thrombolytics for Acute MI Example . FDA-Industry Workshop .
- White , H. D. ( 1998 ). Thrombolytic therapy and equivalence trials . J. Am. Coll. Cardiol. 31 : 494 – 496 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
- World Medical Association . ( 2000 ). Declaration of Helsinki. Ethical principles for medical research involving human subjects . Journal of the American Medical Association 284 : 3043 – 3045 . [CSA] [CROSSREF]